Susan M. O’Brien, MD of University of California Irvine discusses Venetoclax in the management of CLL and where in the therapeutic algorithm it should play a role at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
www.scrippshealth.org/cancer
Advertisement